Dr. Shireen Rizvi, PhD

Claim this profile

Rutgers University

Studies Suicide
2 reported clinical trials
8 drugs studied

Affiliated Hospitals

Image of trial facility.
Rutgers University

Clinical Trials Shireen Rizvi, PhD is currently running

Image of trial facility.

Suicide Prevention Therapies

for University Students

Suicide is the 2nd leading cause of death among college students and suicidal ideation and suicide-related behaviors are a frequent presenting problem at college counseling centers (CCCs), which are overburdened. Studies show that some students respond rapidly to treatment, whereas others require considerably more resources. Evidence-based adaptive treatment strategies (ATSs) are needed to address this heterogeneity in responsivity and complexity. ATSs individualize treatment via decision rules specifying how the type and intensity of an intervention can be sequenced based on risk factors, response, or compliance. The purpose of this multisite study is to investigate the effectiveness of four adaptive treatment strategies (ATSs) to treat college students who report suicidal ideation when first seeking services at their college counseling center This multisite study will enroll moderately to severely suicidal college students in the "emerging adulthood" phase (ages 18-25) seeking services at CCCs. This Sequential Multi-Assignment Randomized Trial (SMART) will have two stages of intervention. In Stage 1, 700 participants from four CCCs will be randomized to 4-8 weeks of: 1) a suicide-focused treatment - Collaborative Assessment and Management of Suicidality (CAMS) or 2) Treatment as Usual (TAU). Sufficient responders to either intervention will discontinue services/be stepped down. Non-responders will be re-randomized to one of two Stage 2 higher intensity/dosage intervention options for an additional 4-16 weeks: 1) CAMS (either continued or administered for the first time) or 2) Comprehensive Dialectical Behavior Therapy (DBT), which includes individual therapy, skills group, and phone/text coaching for the clients and peer consultation for the counselors.
Recruiting1 award N/A4 criteria

More about Shireen Rizvi, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Shireen Rizvi, PhD has experience with
  • CAMS
  • DBT
  • TAU
  • Collaborative Assessment And Management Of Suicidality (CAMS) - Phase 1
  • Collaborative Assessment And Management Of Suicidality (CAMS) - Phase 2
  • Dialectical Behavior Therapy (DBT) - Phase 2

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shireen Rizvi, PhD specialize in?
Shireen Rizvi, PhD focuses on Suicide and other conditions. In particular, much of their work with Suicide has involved treating patients, or patients who are undergoing treatment.
Is Shireen Rizvi, PhD currently recruiting for clinical trials?
Yes, Shireen Rizvi, PhD is currently recruiting for 1 clinical trial in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Shireen Rizvi, PhD has studied deeply?
Yes, Shireen Rizvi, PhD has studied treatments such as CAMS, DBT, TAU.
What is the best way to schedule an appointment with Shireen Rizvi, PhD?
Apply for one of the trials that Shireen Rizvi, PhD is conducting.
What is the office address of Shireen Rizvi, PhD?
The office of Shireen Rizvi, PhD is located at: Rutgers University, New Brunswick, New Jersey 08901 United States. This is the address for their practice at the Rutgers University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.